Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosis.

about

Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosis.

Item

http://www.wikidata.org/entity/Q51367271

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Normalisation of insulin-like ...... e insulin action in cirrhosis.

@en

Normalisation of insulin-like ...... e insulin action in cirrhosis.

@nl

type

Item

label

Normalisation of insulin-like ...... e insulin action in cirrhosis.

@en

Normalisation of insulin-like ...... e insulin action in cirrhosis.

@nl

prefLabel

Normalisation of insulin-like ...... e insulin action in cirrhosis.

@en

Normalisation of insulin-like ...... e insulin action in cirrhosis.

@nl

P1476

Normalisation of insulin-like ...... ve insulin action in cirrhosis

@en

P2093

Hendrik Vilstrup

http://www.w3.org/2001/XMLSchema#string

Jan Frystyk

http://www.w3.org/2001/XMLSchema#string

Jens S Christiansen

http://www.w3.org/2001/XMLSchema#string

Michael F Nielsen

http://www.w3.org/2001/XMLSchema#string

Niels K Aagaard

http://www.w3.org/2001/XMLSchema#string

Peter Holland-Fischer

http://www.w3.org/2001/XMLSchema#string

Thorbjørn Grøfte

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism

Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans

Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.

Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.

Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin.

Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect

Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.

Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver

Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis.

Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.

P304

1511-1518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2011.02599.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jacob Greisen

P577

2011-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21967317

http://www.w3.org/2001/XMLSchema#string